Skip to content

Contrast Nephropathy in Type 2 Diabetes

Prevalence of Contrast Nephropathy in Type 2 Diabetes Patients With Microalbuminuria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03470454
Acronym
VCG4
Enrollment
40
Registered
2018-03-20
Start date
2018-07-01
Completion date
2018-11-30
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Kidney Function Affection Upon Exposure to Radiocontrast, Microalbuminuria

Brief summary

To study the effect of radiocontrast material on kidney functions in diabetics with microalbuminuria

Detailed description

Study design: This study will be an observational prospective cohort study. Study population: Diabetics undergoing any intervention using radiocontrast material for any medical indication in Fayoum universiy hospital will be selected. There will be two arms of the study,each arm will contain 20 patients first arm diabetics on linagelptin, second arm diabetics on other DPP4 inhibitors. Data collection: Patients will be subjected to; full clinical examination,waist hip ratio assessment,BMI assessment fasting blood glucose,Serum uric acid, urine ACR, eGFR will be done before and after the investigation.

Interventions

DRUGLinagliptin Oral Tablet

Linagliptin for blood glucose control

Sponsors

Boehringer Ingelheim
CollaboratorINDUSTRY
Fayoum University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diabetics on DPP 4 inhibitor treatment

Exclusion criteria

* Diabetics on insulin

Design outcomes

Primary

MeasureTime frameDescription
affection of estimated glomerular filtration rateTwo monthsA significant decrease in estimated glomerular filtration rate (eGFR)

Secondary

MeasureTime frameDescription
change in serum uric acidTwo monthsA significant rise in serum uric acid

Other

MeasureTime frameDescription
Affection of albumin creatinine ratioTwo monthsA significant increase in albumin creatinine ratio in urine (ACR)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026